Literature DB >> 17668281

Interaction of MT1-MMP and laminin-5gamma2 chain correlates with metastasis and invasiveness in human esophageal squamous cell carcinoma.

Xiao-Ming Shen1, Yu-Peng Wu, Yan-Bin Feng, Man-Li Luo, Xiao-Li Du, Yu Zhang, Yan Cai, Xin Xu, Ya-Ling Han, Xun Zhang, Qi-Min Zhan, Ming-Rong Wang.   

Abstract

To gain insights into metastatic mechanisms in esophageal squamous cell carcinoma (ESCC), we established sublines (MLuB1 and MLuC1) with different capacity of spontaneous lung metastasis by subcutaneous injection of a human ESCC cell line (EC 9706) into nude mices. The incidence of the mice with lung metastasis produced by MLuC1 (87%) was significantly higher than that of MLuB1 (22%). The gene expression profiles of the two sublines were compared with cDNA arrays containing 5,000 known genes, and 47 genes were differentially expressed > or =2.0 fold. Laminin-5gamma2 chain (Ln-5gamma2) was one of the up-regulated genes in MLuC1 cells. Proteolytically processed forms of gamma2 are known to promote migration of a multitude of epithelial cells in vitro. Western-blotting analysis revealed that degraded fragments of Ln-5gamma2 and active form of membrane-type matrix metalloproteinase-1 (MT1-MMP) in MLuC1 was significantly higher than those in MLuB1. Expression of MT1-MMP was observed in 60 of 75 Ln-5gamma2-positive carcinoma tissues (80%). Co-expression of the two proteins was significantly associated with depth of invasion (P = 0.012). Moreover, proteolytic fragments of Ln-5gamma2 and active forms of MT1-MMP were frequently found in tumor tissues, whereas in the corresponding normal esophageal tissues there were only intact forms of gamma2 and MT1-MMP. siRNA-mediated silencing of MT1-MMP significantly reduced production of gamma2' and gamma2x in MLuC1 cells and inhibited cell migration. The results suggest that MT1-MMP is an enzyme responsible for Ln-5gamma2 cleavage in ESCC, and interaction between them may play a critical role in promoting invasion and metastasis of human ESCC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17668281     DOI: 10.1007/s10585-007-9091-9

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  38 in total

1.  Wide distribution of laminin-5 gamma 2 chain in basement membranes of various human tissues.

Authors:  H Mizushima; N Koshikawa; K Moriyama; H Takamura; Y Nagashima; F Hirahara; K Miyazaki
Journal:  Horm Res       Date:  1998

2.  Mammalian tolloid metalloproteinase, and not matrix metalloprotease 2 or membrane type 1 metalloprotease, processes laminin-5 in keratinocytes and skin.

Authors:  Dallas P Veitch; Pasi Nokelainen; Kelly A McGowan; Thuong-Thuong Nguyen; Ngon E Nguyen; Robert Stephenson; William N Pappano; Douglas R Keene; Suzanne M Spong; Daniel S Greenspan; Paul R Findell; M Peter Marinkovich
Journal:  J Biol Chem       Date:  2002-12-07       Impact factor: 5.157

3.  Expression of the gamma(2) chain of laminin-5 at the invasive front is associated with recurrence and poor prognosis in human esophageal squamous cell carcinoma.

Authors:  H Yamamoto; F Itoh; S Iku; M Hosokawa; K Imai
Journal:  Clin Cancer Res       Date:  2001-04       Impact factor: 12.531

4.  Evaluation of malignancy and the prognosis of esophageal cancer based on an immunohistochemical study (p53, E-cadherin, epidermal growth factor receptor).

Authors:  S Inada; T Koto; K Futami; S Arima; A Iwashita
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

5.  Overexpression of laminin gamma2 chain monomer in invading gastric carcinoma cells.

Authors:  N Koshikawa; K Moriyama; H Takamura; H Mizushima; Y Nagashima; S Yanoma; K Miyazaki
Journal:  Cancer Res       Date:  1999-11-01       Impact factor: 12.701

6.  Correlation between laminin-5 gamma2 chain expression and epidermal growth factor receptor expression and its clinicopathological significance in squamous cell carcinoma of the tongue.

Authors:  Kazuhide Katoh; Yukihiro Nakanishi; Shingo Akimoto; Kimio Yoshimura; Minoru Takagi; Michiie Sakamoto; Setsuo Hirohashi
Journal:  Oncology       Date:  2002       Impact factor: 2.935

7.  Analysis of gene function in somatic mammalian cells using small interfering RNAs.

Authors:  Sayda M Elbashir; Jens Harborth; Klaus Weber; Thomas Tuschl
Journal:  Methods       Date:  2002-02       Impact factor: 3.608

8.  Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer.

Authors:  G I Murray; M E Duncan; P O'Neil; J A McKay; W T Melvin; J E Fothergill
Journal:  J Pathol       Date:  1998-07       Impact factor: 7.996

9.  Smad4 and transforming growth factor beta1 expression in patients with squamous cell carcinoma of the esophagus.

Authors:  Shoji Natsugoe; Che Xiangming; Masataka Matsumoto; Hiroshi Okumura; Saburo Nakashima; Hironori Sakita; Sumiya Ishigami; Masamichi Baba; Sonshin Takao; Takashi Aikou
Journal:  Clin Cancer Res       Date:  2002-06       Impact factor: 12.531

10.  Nonrandom chromosomal imbalances in esophageal squamous cell carcinoma cell lines: possible involvement of the ATF3 and CENPF genes in the 1q32 amplicon.

Authors:  A Pimkhaokham; Y Shimada; Y Fukuda; N Kurihara; I Imoto; Z Q Yang; M Imamura; Y Nakamura; T Amagasa; J Inazawa
Journal:  Jpn J Cancer Res       Date:  2000-11
View more
  11 in total

Review 1.  Tissue inhibitor of metalloproteinases (TIMPs) in heart failure.

Authors:  Linn Moore; Dong Fan; Ratnadeep Basu; Vijay Kandalam; Zamaneh Kassiri
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

2.  Amino-terminal fragments of laminin γ2 chain stimulate migration of metastatic breast cancer cells by interacting with CD44.

Authors:  Hiroki Sato; Shouichi Higashi; Kaoru Miyazaki
Journal:  Clin Exp Metastasis       Date:  2015-05-20       Impact factor: 5.150

3.  TM4SF3 promotes esophageal carcinoma metastasis via upregulating ADAM12m expression.

Authors:  Zhuan Zhou; Yu-Liang Ran; Hai Hu; Jian Pan; Zhi-Feng Li; Li-Zhao Chen; Li-Chao Sun; Liang Peng; Xi-Lu Zhao; Long Yu; Li-Xin Sun; Zhi-Hua Yang
Journal:  Clin Exp Metastasis       Date:  2008-03-26       Impact factor: 5.150

Review 4.  Defining the role of laminin-332 in carcinoma.

Authors:  Cherise M Guess; Vito Quaranta
Journal:  Matrix Biol       Date:  2009-08-15       Impact factor: 11.583

5.  MMP-1/PAR-1 signal transduction axis and its prognostic impact in esophageal squamous cell carcinoma.

Authors:  Hong-Hua Peng; Xi Zhang; Pei-Guo Cao
Journal:  Braz J Med Biol Res       Date:  2011-11-16       Impact factor: 2.590

6.  Cancer cell-secreted IGF2 instigates fibroblasts and bone marrow-derived vascular progenitor cells to promote cancer progression.

Authors:  Wen Wen Xu; Bin Li; Xin Yuan Guan; Sookja K Chung; Yang Wang; Yim Ling Yip; Simon Y K Law; Kin Tak Chan; Nikki P Y Lee; Kwok Wah Chan; Li Yan Xu; En Min Li; Sai Wah Tsao; Qing-Yu He; Annie L M Cheung
Journal:  Nat Commun       Date:  2017-02-10       Impact factor: 14.919

Review 7.  Skin basement membrane: the foundation of epidermal integrity--BM functions and diverse roles of bridging molecules nidogen and perlecan.

Authors:  Dirk Breitkreutz; Isabell Koxholt; Kathrin Thiemann; Roswitha Nischt
Journal:  Biomed Res Int       Date:  2013-03-21       Impact factor: 3.411

8.  Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease.

Authors:  Dong Fan; Abhijit Takawale; Jiwon Lee; Zamaneh Kassiri
Journal:  Fibrogenesis Tissue Repair       Date:  2012-09-03

9.  Amino-terminal fragments of laminin γ2 chain retract vascular endothelial cells and increase vascular permeability.

Authors:  Hiroki Sato; Jun Oyanagi; Eriko Komiya; Takashi Ogawa; Shouichi Higashi; Kaoru Miyazaki
Journal:  Cancer Sci       Date:  2014-01-07       Impact factor: 6.716

10.  Polyphyllin I suppresses the formation of vasculogenic mimicry via Twist1/VE-cadherin pathway.

Authors:  Ting Xiao; Weilong Zhong; Jianmin Zhao; Baoxin Qian; Huijuan Liu; Shuang Chen; Kailiang Qiao; Yueyang Lei; Shumin Zong; Hongzhi Wang; Yuan Liang; Heng Zhang; Jing Meng; Honggang Zhou; Tao Sun; Yanrong Liu; Cheng Yang
Journal:  Cell Death Dis       Date:  2018-09-05       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.